Month: April 2021

Animals can experience anxiety the same way that humans can, and seeing them in distress can be heartbreaking. With the help of a clinical animal behaviourist, we explore how we can better support our companions Many of us will be familiar with anxiety or depression, but did you know that our furry friends can experience
0 Comments
The best medical school program for primary care is at the University of Washington in Seattle, according to the latest rankings by US News & World Report. The University of California, San Francisco, ranks second and the University of North Carolina at Chapel Hill, third, in the rankings released March 30. Rounding out the top
0 Comments
Deprivation among society at large is ‘driving’ Covid-19 disparities among minority ethnic groups – predominantly South Asian and Black African or Caribbean populations – and could be considered the main cause of disproportionate infection rates, hospitalization and deaths experienced by these populations, according to new analysis from the University of Leicester. The study, supported by
0 Comments
udenafil Treatment for Single Ventricle Heart Disease Mezzion Announces Re-Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single Ventricle Heart Disease SEOUL, South Korea, March 28, 2021 /PRNewswire/ – Mezzion Pharma Co. Ltd. (140410.KQ), announced today that it has re-submitted a New Drug Application (NDA) to
0 Comments
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases, today announced the U.S. Food and Drug Administration (FDA) approved Arcalyst (rilonacept), a weekly, subcutaneously-injected, recombinant fusion protein that blocks interleukin-1 alpha (IL-1α)
0 Comments
March 24, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy March 24, 2021 — FDA Safety Communication Purpose: To inform the public and healthcare providers that FDA has required and approved safety labeling changes to the Prescribing Information for Shingrix (Zoster Vaccine Recombinant, Adjuvanted) to include a new warning about the risk for Guillain-Barré Syndrome (GBS)
0 Comments
Coronavirus has rocked the nation with a year of restrictions, lockdowns, missed gatherings and events, isolation and a staggering loss of more than half a million American lives. As the pandemic stretches into a second year, Americans struggling with increased rates of depression, anxiety, and insomnia are looking for mental health support, and providers are
0 Comments
A team of researchers has sought to mitigate the mental health impacts of COVID-19 on adolescents by harnessing previous research on youth physical and mental health. Their review also drew on the psychological stressors of the 2011 Great East Japan Earthquake and Tsunami on children. The results were published in the Tohoku Journal of Experimental
0 Comments
Author Nikesh Shukla reveals how his writing career has shaped him as a person, and why he’s sharing his most vulnerable self through his words… When Nikesh Shukla is asked to introduce himself on Happiful’s podcast ‘I am. I have’, he pauses for a moment. “I always feel weird answering these questions, because my natural
0 Comments
With a new gel and a new patch joining the existing line-up of contraceptive options, it seems that women have many choices these days to prevent a pregnancy.  On the face of it, yes. Condoms, spermicide, IUDs, the pill, a cervical cap, a diaphragm, the gel, are part of the list.  But the birth control
0 Comments
Posted on April 1, 2021 by Ajla Bedzetovic At Atria Senior Living, our mission is to serve the needs of older adults and their families. To that end, one of the ways we deliver on that mission is to develop new senior living communities. Our latest such development in the works: Atria Cary in none other than Cary, North Carolina.  An idyllic setting in the Tar Heel State 
0 Comments
Bounced between diagnoses, it took some time before Beth got the answers she needed. But once she did, she began her journey to understanding autism and now she’s reaching out to help others Throughout my life, I’ve always felt that I was different. A square peg in a round hole. Someone without a place. At
0 Comments
A minimally invasive blood test along with artificial intelligence (AI) may flag early-stage Alzheimer’s disease (AD), raising the prospect of early intervention when effective treatments become available. In a study, investigators used six AI methodologies, including Deep Learning, to assess blood leukocyte epigenomic biomarkers. They found more than 150 genetic differences among study participants with
0 Comments
HOUSTON, March 30, 2021 /PRNewswire/ – Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the U.S. Food and Drug Administration (“FDA”) has approved its request for Fast Track Designation for its drug, Annamycin, for
0 Comments
ublituximab Treatment for Chronic Lymphocytic Leukemia TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in Combination with Ukoniq (umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the completion
0 Comments
KENILWORTH, N.J.–(BUSINESS WIRE) March 23, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of patients with locally advanced or metastatic esophageal or gastroesophageal junction (GEJ) (tumors with epicenter 1 to
0 Comments
March 31, 2021 Audience: Patient, Health Professional, Pharmacy, Neurology, Cardiology, Psychiatry ISSUE: An FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart disease who are taking the seizure and mental health medicine Lamictal (lamotrigine). FDA wants to evaluate whether other medicines in the same
0 Comments
Overweight children and adolescents receiving chemotherapy for treatment of leukemia are less successful battling the disease compared to their lean peers. Now, research conducted at the Cancer and Blood Disease Institute at Children’s Hospital Los Angeles indicates that modest changes in diet and exercise can greatly increase survival in youth treated for acute lymphoblastic leukemia
0 Comments
Overdose deaths involving both opioids and either cocaine or psychostimulants were rising long before anyone heard of COVID-19, a National Center for Health Statistics (NCHS) report showed. From 2009 to 2019, deaths involving both cocaine and opioids rose more quickly than those involving cocaine but not opioids, reported Holly Hedegaard, MD, of the NCHS Division
0 Comments
Nutritionist Resource member Marie Jarvis joins Happiful’s podcast to talk about IBS, symptom tracking and why talking about poo is good for you Nutritional Therapist and Health Coach Marie Jarvis is well placed to talk about Irritable Bowel Syndrome (IBS) after suffering with it since she was a teenager. From chronic constipation to sudden urges
0 Comments